Wire report
Lupus patients in England in remission after pioneering NHS trial of GM therapy
Doctors say therapy that genetically modifies person’s T-cells could offer cure for chronic autoimmune disease Five lupus patients in England are in remission after being treated with a revolutionary therapy that genetically modifies their own cells, in a medical breakthrough that could offer people a cure, doctors have said. CAR (chimeric antigen receptor) T-cell therapy involves removing a type of white blood cell also called T lymphocytes, which are crucial for hunting out infected or damaged cells, and engineering them to spot and destroy disease. The T-cells are then fed back into the patient via an infusion to reset their immune system. Continue reading...
coverage / Wire report
Get updates, read source context, send useful records, share the story, or support the reporting work from the reading page.
Doctors say therapy that genetically modifies person’s T-cells could offer cure for chronic autoimmune disease Five lupus patients in England are in remission after being treated with a revolutionary therapy that genetically modifies their own cells, in a medical breakthrough that could offer people a cure, doctors have said. CAR (chimeric antigen receptor) T-cell therapy involves removing a type of white blood cell also called T lymphocytes, which are crucial for hunting out infected or damaged cells, and engineering them to spot and destroy disease. The T-cells are then fed back into the patient via an infusion to reset their immune system. Continue reading...
Check the original link, updates, and responses when a detail is contested.
Open topic or search related wording such as records, sources, agencies, dates, and locations.
What happened
According to The Guardian’s linked report, Lupus patients in England in remission after pioneering NHS trial of GM therapy, Doctors say therapy that genetically modifies person’s T-cells could offer cure for chronic autoimmune disease Five lupus patients in England are in remission after being treated with a revolutionary therapy that genetically modifies their own cells, in a medical breakthrough that could offer people a cure, doctors have said. CAR (chimeric antigen receptor) T-cell therapy involves removing a type of white blood cell also called T lymphocytes, which are crucial for hunting out infected or damaged cells, and engineering them to spot and destroy disease. The T-cells are then fed back into the patient via an infusion to reset their immune system. Continue reading…
Context
The development sits in VINI’s Science coverage for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The original item is dated 2026-06-11T23:01:28+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: Lupus patients in England in remission after pioneering NHS trial of GM therapy via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
Keep following
This file can keep developing
vininews.com uses reader tips, public records, right-of-reply requests, corrections, and follow-up reporting to keep important stories current.
Support and subscriptions never buy coverage, placement, suppression, or corrections.
This VINI report keeps the original publisher link available and does not republish third-party article bodies without rights clearance. 1 reference listed.
Source links
- Lupus patients in England in remission after pioneering NHS trial of GM therapyThe Guardian - 2026-06-11T23:01:28+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.
No approved comments yet.
Substantive, civil comments can be submitted by approved account holders.